Evidence map›Paper›PMID 33002292›Full record

ArticleJournal of cellular and molecular medicine2020

Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells.

Tamao Shinohara, Kevin Y Urayama, Atsushi Watanabe, Koshi Akahane, Kumiko Goi, Meixian Huang, Keiko Kagami, Masako Abe, Kanji Sugita, Yukinori Okada and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Tamao ShinoharaDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.ORCID 0000-0003-0714-1239
Kevin Y UrayamaDepartment of Social Medicine, National Center for Child Health and Development, Tokyo, Japan.
Atsushi WatanabeDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.ORCID 0000-0002-4181-8111
Koshi AkahaneDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.ORCID 0000-0001-8591-1281
Kumiko GoiDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Meixian HuangDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Keiko KagamiDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Masako AbeDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Kanji SugitaDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.
Yukinori OkadaDepartment of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka, Japan.
Hiroaki GotoHematology/Oncology and Regenerative Medicine, Kanagawa Children's Medical Center, Yokohama, Japan.
Masayoshi MinegishiTohoku Block Center, Japanese Red Cross Society, Sendai, Japan.
Shotaro IwamotoDepartment of Pediatrics, Mie University Graduate School of Medicine, Tsu, Japan.
Takeshi InukaiDepartment of Pediatrics, School of Medicine, University of Yamanashi, Chuo, Japan.ORCID 0000-0002-4783-2184
University of Yamanashi · JPJapanese Red Cross Society, Japan · JPKanagawa Children's Medical Center · JPMie University · JPSt. Luke's International University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of genetic variants associated with glucocorticoids (GC) sensitivity of leukaemia cells may provide insight into potential drug targets and tailored therapy. In the present study, within 72 leukaemic cell lines derived from Japanese patients with B-cell precursor acute lymphoblastic leukaemia (ALL), we conducted genome-wide genotyping of single nucleotide polymorphisms (SNP) and attempted to identify genetic variants associated with GC sensitivity and NR3C1 (GC receptor) gene expression. IC50 measures for prednisolone (Pred) and dexamethasone (Dex) were available using an alamarBlue cell viability assay. IC50 values of Pred showed the strongest association with rs904419 (P = 4.34 × 10

Indexed as

Gene Expression Regulation, LeukemicGenetic VariationCell Line, TumorDexamethasoneDrug Screening Assays, AntitumorGene Expression ProfilingGenotypeGlucocorticoidsHumansInhibitory Concentration 50JapanPharmacogeneticsPolymorphism, Single NucleotidePrecursor Cell Lymphoblastic Leukemia-LymphomaPrednisoloneReceptors, GlucocorticoidDexamethasoneGlucocorticoidsPrednisoloneReceptors, Glucocorticoidacute lymphoblastic leukaemiagenome-wide association studiesglucocorticoid sensitivity

Identifiers

PMID33002292
PMCPMC7701530
OpenAlexW3091028675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.